Chair: R. Klingenberg (Bad Nauheim), B. H. Rauch (Oldenburg)
| 11:30 | (V1415) | Introduction |
| R. Klingenberg (Bad Nauheim) | ||
| 11:35 | (V1416) | Adaptive immunity in acute and chronic coronary syndromes – therapeutic options |
| Z. Mallat (Cambridge, UK) | ||
| 11:50 | Discussion | |
| 11:55 | (V1417) | Adaptive immunity in congestive heart failure and after myocardial infarction in particular |
| S. Frantz (Würzburg) | ||
| 12:10 | Discussion | |
| 12:15 | (V1418) | Innate immunity as a therapeutic target in cardiovascular disease – An outlook |
| N. Gerdes (Düsseldorf) | ||
| 12:30 | Discussion | |
| 12:35 | (V1419) | What to watch for when using immunomodulatory agents – Insights from rheumatology |
| U. Müller-Ladner (Bad Nauheim) | ||
| 12:50 | Discussion | |
| 12:55 | (V1420) | Conclusion |
| B. H. Rauch (Oldenburg) | ||
| General assembly of the working group 22 on Friday, 14 April 2023 11:00 - 11:30 in hall 9 |
| 13:00 - 14:00 | DGK-General Assembly part 1 in hall 4 |